Kidney disease, leading to kidney failure, afflicts disproportionately more black people than white people. Thus, there is a huge burden of kidney healthcare costs among black people all over the ...

Q4 2024 Management View CEO Jon Congleton highlighted the company's focus on advancing its pivotal trials for lorundrostat, targeting dysregulated aldosterone in patients with uncontrolled and ...

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map' of kidney function to ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

High blood pressure, or hypertension, is the leading cause of global mortality and cardiovascular disease. While there is no ...

We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...

Intensive blood pressure control in hypertensive chronic kidney disease (CKD) provides a survival advantage and other benefits.

Kidney disease affects millions of Americans, with Black communities facing disproportionately higher risks due to genetic factors, socioeconomic challenges, ...

The findings are highly significant for the estimated one in three Australians who have hypertension, which is a leading cause of stroke, heart disease and kidney disease. "We had evidence that ...

“To address the growing problem of hypertension and heart and kidney disease in India, especially in rural areas, we need to make low-sodium, potassium-enriched salts affordable and widely availabl ...